Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort

Introduction: Second-generation long-acting injectable antipsychotics (SG-LAIAs) may improve outcomes compared to other antipsychotics. Real-world studies using linked administrative databases play an important role in assessing the comparative effectiveness of antipsychotic medications. Methods: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzen, Donica, Bolton, James M., Leong, Christine, Kuo, I fan, Alessi-Severini, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160742/
https://www.ncbi.nlm.nih.gov/pubmed/35662722
http://dx.doi.org/10.3389/fphar.2022.879224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160742/
https://www.ncbi.nlm.nih.gov/pubmed/35662722
http://dx.doi.org/10.3389/fphar.2022.879224

Ejemplares similares